Mitochondrial Disease: Difference between revisions

Jump to navigation Jump to search

Mitochondrial Disease (view source)

Revision as of 17:39, 4 January 2024

58 bytes removed ,  10 months ago
no edit summary
No edit summary
No edit summary
Line 17: Line 17:
[https://pubmed.ncbi.nlm.nih.gov/33752971/  Hypoxia ameliorates brain hyperoxia and NAD(+) deficiency in a murine model of Leigh syndrome]
[https://pubmed.ncbi.nlm.nih.gov/33752971/  Hypoxia ameliorates brain hyperoxia and NAD(+) deficiency in a murine model of Leigh syndrome]


Jain IH, Zazzeron L, Goli R, et al. Hypoxia as a therapy for mitochondrial disease. Science. Apr 1 2016;352(6281):54-61. doi:10.1126/science.aad9642
[https://pubmed.ncbi.nlm.nih.gov/26917594/ Hypoxia as a therapy for mitochondrial disease]


[https://www.openanesthesia.org/vodcasts/anesthetic-considerations-in-patients-with-mitochondrial-disease/ Open Anesthesia: Anesthetic Considerations in Patients with Mitochondrial Disease]
[https://www.openanesthesia.org/vodcasts/anesthetic-considerations-in-patients-with-mitochondrial-disease/ Open Anesthesia: Anesthetic Considerations in Patients with Mitochondrial Disease]


[https://pubmed.ncbi.nlm.nih.gov/37770252/ Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome]
[https://pubmed.ncbi.nlm.nih.gov/37770252/ Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome]
Retrieved from "https://pedsanesthesia.net/wiki/index.php/Special:MobileDiff/4072"

Navigation menu